Publications by authors named "Tereza L Menegucci Zutin"
The Influence of Body Fat and Lean Mass on HbA1c and Lipid Profile in Children and Adolescents with Type 1 Diabetes Mellitus.
Thais Menegucci Eduardo Federighi Baisi Chagas Barbara de Oliveira Zanuso Karina Quesada Jesselina Francisco Dos Santos Haber Tereza Laís Menegucci Zutin
Diseases
September 2023
Glycated hemoglobin (HbA1c) is used to assess glycemic control in Type 1 diabetes (DM1) patients. Apolipoproteins play an essential role in DM1 pathophysiology and may be associated with complications and HbA1c. This cross-sectional observational study of 81 children and adolescents of both sexes diagnosed with DM1 investigated the relationship between body fat distribution and lean mass with HbA1C and apolipoprotein values, analyzing biochemical and body composition measurements.
View Article and Find Full Text PDFThe Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review.
Rodrigo Zamignan Carpi Sandra M Barbalho Katia Portero Sloan Lucas Fornari Laurindo Heron Fernando Gonzaga Tereza L Menegucci Zutin
Int J Mol Sci
August 2022
Article Synopsis
- Changes in gut microbiota due to environmental and genetic factors can disrupt intestinal balance, leading to metabolic and immune issues that heighten the risk of non-alcoholic fatty liver disease (NAFLD).
- Probiotics, prebiotics, and synbiotics are being explored as potential strategies to regulate gut microbiota and improve health in liver disease patients, with research indicating they can positively affect inflammation, glycemia, and liver injury indicators.
- Although these microbiota-modulating treatments aren't a cure, they can serve as useful adjunct therapies for NAFLD by enhancing gut health and immune response, thereby potentially mitigating liver damage.